2023 年第三季度报告 单位：元 币种：人民币 证券代码：600315 证券简称：上海家化 上海家化联合股份有限公司 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 第三季度财务报表是否经审计 一、 主要财务数据 本报告期 | --- | --- | --- | --- | --- | |------------------------------------------------|------------------|------------------------------|------------------|-------------------------------| | 项目 | 本报告期 | 比上年同 期增减变 动幅度 (%) | 年初至报告期末 | 末比上年同期 增减变动幅度 (%) | | 营业收入 | 1,461,792,624.23 | -10.82 | 5,091,247,553.86 | -4.91 | | 归属于上市公司股东的 净利润 | 93,134,404.79 | - ...

一、董事会会议召开情况 上海家化联合股份有限公司八届十三次董事会于 2023 年 10 月 25 日以现场及 通讯方式召开，会议通知于 2023 年 10 月 15 日以邮件方式发出。会议应参加董事 7 人，实际参加董事 7 人，会议由董事长潘秋生先生主持，监事和高级管理人员 列席了会议，符合《公司法》及《公司章程》的有关规定。 二、董事会会议审议情况 证券代码：600315 证券简称：上海家化 公告编号：临 2023-037 上海家化联合股份有限公司 八届十三次董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 公司 2023 年第三季度报告请见上海证券交易所网站。 2、审议通过公司组织机构调整的议案。 表决情况：7 票同意，0 票反对，0 票弃权，通过本议案。 为进一步提升公司运营质量、激活组织效率、加速业务增长，公司决定对国 内业务组织机构进行调整： 公司设立美容护肤与母婴事业部、个护家清事业部、海外事业部，以事业部 为决策主体，并对业绩结果负责。 特此公告。 会议审议并通过了如下议案： 1、审议通过公 ...

证券代码：600315 证券简称：上海家化 公告编号：临 2023-038 上海家化联合股份有限公司 关于 2023 年第三季度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据上海证券交易所《上市公司行业信息披露指引第十三号—化工》的要求、 现将公司 2023 年第三季度主要经营数据披露如下： 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 产量(支) | 销量(支) | 营业收入（元） | | --- | --- | --- | --- | | 护肤 | 31,504,086 | 24,870,304 | 414,080,364.25 | | 个护家清 | 59,844,971 | 60,265,500 | 545,090,241.23 | | 母婴 | 27,824,298 | 28,574,890 | 443,340,189.16 | | 合作品牌 | 2,678.444 | 3,079,501 | 57,117,927.32 | 注：护肤品类，包括佰草集、玉泽、典萃、高夫、双妹、 ...

4. 其他说明 □适用 √不适用 (四) 投资状况分析 1. 对外股权投资总体分析 √适用 □不适用 详见下述 13 / 175 2023 年半年度报告 (1).重大的股权投资 □适用 √不适用 (2).重大的非股权投资 □适用 √不适用 (3).以公允价值计量的金融资产 √适用 □不适用 单位：元 币种：人民币 | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------------------------|------------------|-----------------------|------------------------------|-----------------|----------------|--------------------|--------------|------------------| | 资产类别 | 期初数 | 本期公允价值 变动损益 | 计入权益的累 计公允价值变 动 | 本期计提 的减值 | 本期购买金额 | 本期出售/赎回 金额 | 其他变动 | 期末数 | | 私募基金 | 625, ...

国浩律师（上海）事务所 关 于 上海家化联合股份有限公司 2020 年、2022 年限制性股票激励计划 部分限制性股票回购注销实施 2023 年 9 月 的 法律意见书 上海市北京西路 968 号嘉地中心 27 楼接待中心 邮编：200041 27/F, Garden Square, 968 West Beijing Road, Shanghai 200041, China T. +86 21 5234 1668 F. +86 21 5234 1670 E. grandallsh@grandall.com.cn W. www.grandall.com.cn 法律意见书 致：上海家化联合股份有限公司 国浩律师（上海）事务所 法律意见书 国浩律师（上海）事务所 关于上海家化联合股份有限公司 2020 年、2022 年限制性股票 激励计划部分限制性股票回购注销实施的 国浩律师（上海）事务所（以下简称"本所"）接受上海家化联合股份有限公 司（以下简称"上海家化"或"公司"）的委托，作为其实施 2020 年限制性股票激 励计划和 2022 年限制性股票激励计划的特聘专项法律顾问。 本所律师根据《中华人民共和国公司法》（ ...

重要内容提示： ●回购注销原因：上海家化联合股份有限公司（以下简称"公司"）于2023年 6月6日召开八届十一次董事会，于2023年6月28日召开2022年年度股东大会，审 议通过了《关于回购注销部分限制性股票的议案》，鉴于2020年限制性股票激 励计划部分激励对象已离职，以及第二个解除限售期公司层面业绩考核未达 标；2022年限制性股票激励计划第一个解除限售期公司层面业绩考核未达标， 公司拟回购注销相应部分限制性股票。根据《上市公司股权激励管理办法》、 公司《2020年限制性股票激励计划（2022年8月修订）》（以下简称"《2020年 激励计划》"）、公司《2022年限制性股票激励计划（草案）》（以下简称 "《2022年激励计划》"）的相关规定，公司将上述激励对象已获授但尚未解除 限售的2,649,334股限制性股票进行回购注销处理。 ●本次注销股份的有关情况 | 回购股份数量（股） | 注销股份数量（股） | 注销日期 | | | | | --- | --- | --- | --- | --- | --- | | 2,649,334 | 2,649,334 | 2023 年 9 | 月 | 13 | 日 ...

Net Profit Changes - Net profit of Shanghai Jahwa Sales Co., Ltd. decreased year-on-year due to a decline in offline channel traffic and lower average temperatures in the first half of the year, leading to reduced revenue. Additionally, the proportion of high-margin product sales decreased, and procurement costs increased, resulting in a year-on-year decline in gross margin[7] - Net profit of Shanghai Jahwa Hainan Daily Chemical Co., Ltd. increased year-on-year due to personnel restructuring, which reduced employee compensation and share-based payment expenses[7] - Net profit of Abundant Merit Limited decreased year-on-year due to persistent inflationary pressures in the UK since the beginning of the year, leading to a decline in consumer confidence and willingness to spend. The overall UK infant market also declined, and intensified competition in the feeding category caused distributors to reduce inventory, resulting in decreased revenue and gross margin[7] - Net profit rose to 300,997,104.25 yuan, a significant increase of 90.9% compared to 157,672,141.64 yuan in the prior period[62] - Net profit attributable to the parent company's owners was 464,000,385.16 RMB, compared to 65,063,377.16 RMB in the previous year[72] - Net profit attributable to shareholders of the listed company was 301 million yuan, an increase of 90.90% year-on-year[171] Intangible Assets - The company's intangible assets formed through internal R&D accounted for 3.38% of the total intangible assets balance at the end of the period[11] - The company's total book value of intangible assets at the end of the period was RMB 817,524,374.30, compared to RMB 790,259,580.90 at the beginning of the period[11] - Intangible assets include land use rights, computer software, trademarks, patents, R&D projects, and others, recognized when economic benefits are probable and costs are reliably measurable[135] - The expected useful lives of intangible assets are determined based on the period they can bring economic benefits to the company, with land use rights typically ranging from 30-50 years[155] - Internal R&D expenditures are classified into research and development phases, with development costs capitalized only if they meet specific criteria[153] Revenue and Sales Performance - The company's total social retail sales of consumer goods increased by 8.2% year-on-year from January to June 2023, with cosmetics sales increasing by 8.6% (above-quota retail sales of goods)[15] - The company achieved a skincare category revenue of 872 million yuan in the first half of 2023, a year-on-year increase of 7.16%[46] - Domestic business revenue reached 2.843 billion yuan in the first half of 2023, with a 10.20% year-on-year growth in the second quarter[46] - Overseas business revenue declined by 12.28% to 786 million yuan in the first half of 2023 due to inflation and market competition in the UK[46] - Total revenue for the first half of 2023 reached 1,779,340,449.53 RMB, an increase from 1,662,081,036.61 RMB in the same period last year[73] - Revenue for the reporting period was 3.629 billion yuan, a decrease of 2.30% year-on-year[171] - Revenue from skincare products was 871 million yuan, an increase of 7.16% year-on-year, accounting for 24.06% of total revenue[172] - Revenue from personal care and home cleaning products was 1.724 billion yuan, a decrease of 0.50% year-on-year, accounting for 47.59% of total revenue[172] - Revenue from maternal and child products was 911 million yuan, a decrease of 10.91% year-on-year, accounting for 25.14% of total revenue[172] - Domestic revenue accounted for 78.30% of total revenue, with online channels contributing 27.14% and offline channels contributing 51.16%[183] Financial Position and Assets - The company's total balance at the end of the period was RMB 4,959,536.83, compared to RMB 6,484,291.16 at the beginning of the period[5] - The company's total reduction in the current period was RMB 1,524,754.33, including RMB 1,979,346.43 from disposals and RMB -454,592.10 from foreign currency translation differences[5] - The company's total balance at the end of the period was RMB 2,834,392.00, compared to RMB 2,602,171.00 at the beginning of the period[11] - Total assets as of June 30, 2023, amounted to 6,429,692,211.51 RMB, with current assets including 1,146,390,540.79 RMB in cash and cash equivalents, 2,354,922,314.10 RMB in trading financial assets, and 1,319,035,280.98 RMB in accounts receivable[59] - Inventory as of June 30, 2023, was 1,022,532,646.65 RMB, with provisions for inventory write-downs due to obsolescence for raw materials and finished goods[51] - Prepaid expenses increased to 156,430,311.02 RMB as of June 30, 2023, compared to 72,376,159.49 RMB at the end of 2022[59] - Long-term equity investments stood at 424,814,735.37 RMB as of June 30, 2023, showing a slight increase from 414,783,637.24 RMB at the end of 2022[59] - Fixed assets decreased to 845,300,402.46 RMB as of June 30, 2023, from 863,393,441.45 RMB at the end of 2022[59] - Total assets grew to 11,050,398,817.24 yuan, up 5.0% from 10,521,803,972.73 yuan at the end of 2022[65][67] - Current assets increased to 5,534,295,106.47 yuan, a 6.6% rise from 5,190,136,949.87 yuan at the end of 2022[65][67] - Long-term equity investments reached 3,053,305,894.89 yuan, slightly up from 3,049,173,351.73 yuan at the end of 2022[67] - Accounts receivable decreased to 1,704,867,908.77 yuan, down 0.8% from 1,718,327,854.14 yuan at the end of 2022[65] - Inventory increased to 634,220,222.22 yuan, up 19.5% from 530,686,297.03 yuan at the end of 2022[65] - Total non-current assets: 6,037,835,870.26[83] - Total assets: 12,467,528,081.77[83] Liabilities and Equity - The company's total guarantee amount (including guarantees for subsidiaries) was 731.456 million yuan, accounting for 9.65% of net assets[40] - The company provided guarantees for subsidiaries, with a total guarantee amount of 2,669,841.24 RMB during the reporting period, and the balance of guarantees for subsidiaries was 0 as of the end of the reporting period[54] - Total liabilities as of the reporting period amounted to 4,888,071,751.83 RMB, slightly lower than the previous year's 5,020,001,233.87 RMB[70] - Total equity attributable to the parent company's owners was 7,579,456,329.94 RMB, an increase from 7,249,484,579.10 RMB in the previous year[70] - Current liabilities rose to 2,534,868,903.78 yuan, a 26.0% increase from 2,011,569,527.84 yuan at the end of 2022[67] - Total current liabilities: 3,661,761,316.40[83] - Long-term borrowings: 512,019,200.00[83] - Total liabilities increased to 3,034,828,512.18 RMB from 2,532,021,301.31 RMB, reflecting a significant rise in the company's debt obligations[86] - Total owner's equity slightly increased to 8,015,570,305.06 RMB from 7,989,782,671.42 RMB, indicating stable equity growth[86] - The company's deferred income decreased to 465,461,729.88 RMB from 484,877,192.90 RMB, indicating a reduction in future income obligations[86] - The company's long-term employee benefits payable decreased to 11,519,591.88 RMB from 12,467,130.52 RMB, reflecting a reduction in long-term liabilities[86] - The company's estimated liabilities remained relatively stable at 22,116,090.76 RMB compared to 22,119,404.18 RMB in the previous period[86] - The company's total non-current liabilities increased to 499,959,608.40 RMB from 520,451,773.47 RMB, showing a slight decrease in long-term liabilities[86] Cash Flow and Investments - The company's investment in Ping An Consumer Technology Fund (Phase I and III) contributed to an increase in non-recurring gains[45] - The company's operating cash flow decreased due to a 28.07 million GBP payment for equity incentive exercises and increased marketing and R&D expenses[45] - Operating cash flow net amount: 65,628,098.57[76] - Investment cash inflow subtotal: 980,509,623.04[76] - Investment cash outflow subtotal: 1,358,366,050.67[76] - Net cash flow from investment activities: -377,856,427.63[76] - Net cash flow from financing activities: -244,606,044.12[76] - Net increase in cash and cash equivalents: -538,802,195.39[76] - Operating cash flow for the reporting period was 65.63 million yuan, a decrease of 84.91% year-on-year[171] Expenses and Costs - The company's prepaid taxes increased to 47.15 million yuan from 16.72 million yuan at the beginning of the period[36] - The company's bank deposits and interest due within one year amounted to 325.89 million yuan[36] - The company's total development expenditure for infant care products and maternal and infant feeding products was 2.11 billion yuan[30] - Sales expenses for the first half of 2023 were 494,009,175.07 RMB, significantly higher than the 309,741,402.41 RMB in the same period last year[73] - R&D expenses increased to 68,599,355.76 RMB in the first half of 2023, up from 57,212,823.31 RMB in the previous year[73] - R&D expenses increased to 77,528,542.90 yuan, up 18.4% from 65,485,885.86 yuan in the previous period[62] - Total operating costs for the first half of 2023 were 3,422,862,715.58 RMB, down from 3,504,737,788.06 RMB in the previous year[86] - Sales expenses for the first half of 2023 were 1,579,715,589.92 RMB, a decrease from 1,606,941,203.67 RMB in the same period last year[86] - Management expenses for the first half of 2023 were 302,997,124.56 RMB, down from 319,261,702.04 RMB in the previous year[86] Other Financial Metrics - The company's total social retail sales of consumer goods increased by 8.2% year-on-year from January to June 2023, with cosmetics sales increasing by 8.6% (above-quota retail sales of goods)[15] - The company's main brands include Herborist, Yuesai, GF, Maxam, Diancui, Twin Lotus, Chinfie, Tommee Tippee, Liushen, and Jiean, as well as cooperative brands such as Pien Tze Huang (oral care), Femfresh, and Batiste[15] - The company donated over 100,000 yuan worth of products to healthcare workers in Shanghai and 30,000 yuan worth of daily necessities to a children's aid center in Anhui[25] - Bad debt provisions as of June 30, 2023, totaled 12,979,055.95 RMB, with a decrease of 4,669,106.64 RMB in provisions during the period[60] - Other comprehensive income after tax improved significantly to 163,003,280.91 yuan, compared to -92,608,764.48 yuan in the previous period[62] - Other comprehensive income that will be reclassified to profit or loss was 171,404,961.36 RMB, compared to a loss of 91,513,862.02 RMB in the previous year[72] - Gross profit margin increased by 0.34 percentage points to 60.25%[171] - Inventory at the end of the reporting period was 1.023 billion yuan, with inventory turnover days increasing by 13 days[171] - Accounts receivable at the end of the reporting period was 1.319 billion yuan, with accounts receivable turnover days increasing by 2 days[171] - Other receivables with a total book value of 62,515,032.05 RMB, broken down by age: within 1 year (36,768,084.63 RMB), 1-2 years (3,917,896.90 RMB), 2-3 years (11,687,587.38 RMB), and over 3 years (10,141,463.14 RMB)[184] - Bad debt provision for other receivables decreased by 4,669,106.64 RMB, resulting in a total provision of 12,979,055.95 RMB at the end of the period[186] - The company provides internal retirement benefits, which are treated similarly to severance benefits, with liabilities recognized and expensed when the conditions for severance benefits are met[187] - The company uses the Black-Scholes option pricing model to determine the fair value of equity-settled share-based payments[189] - The company recognizes revenue from services based on the progress of completed services, with adjustments made at each balance sheet date to reflect changes in performance[192] - Government grants related to daily activities are included in operating profit, while those unrelated are recorded as non-operating income or expenses[194] - Deferred tax assets and liabilities are recognized based on temporary differences between the tax base and the book value of assets and liabilities, with adjustments made at each balance sheet date[195] - The company recognizes estimated liabilities for quality assurance and loss contracts when it is probable that economic benefits will flow out and the amount can be reliably measured[200] Accounting Policies and Practices - Financial assets are terminated when the contractual rights to cash flows cease, risks and rewards are transferred, or control is relinquished[108] - Financial liabilities are classified as either measured at amortized cost or at fair value with changes in profit or loss[110] - Inventory is initially measured at cost, including purchase, processing, and other costs, with specific valuation methods for different types of inventory[112] - Inventory impairment is recognized when the cost exceeds the net realizable value, calculated based on estimated selling price minus costs to complete and sell[113] - Long-term equity investments include investments in subsidiaries and associates, with different accounting methods applied[114][115] - Fixed assets are depreciated using the straight-line method over their useful lives, with annual reviews of useful life, residual value, and depreciation method[119][120] - Borrowing costs are capitalized when directly attributable to the acquisition, construction, or production of qualifying assets, and cease when the asset is ready for use[123] - Control over an investee is determined by the power to influence returns through participation in relevant activities[127] - Joint control requires unanimous agreement among parties sharing control over an arrangement[128] - Fixed assets are recognized only when it is probable that the associated economic benefits will flow to the company and the cost can be reliably measured[129] - Long-term prepaid expenses, such as insurance premiums and leasehold improvements, are amortized over their expected benefit periods[144] - Employee benefits include short-term compensation, post-employment benefits, termination benefits, and other long-term benefits[145] - The company's post-employment benefits are primarily defined contribution plans, including basic pension and unemployment insurance[151] - Non-current asset disposal losses amounted to -34,353.98 RMB during the reporting period[150] - The company conducts impairment tests for long-term assets, including goodwill, and recognizes impairment losses if the recoverable amount is lower than the carrying amount[158] - Short-term employee benefits, such as salaries, bonuses, and allowances, are recognized as liabilities and expensed in the period they are incurred[161]

一、董事会会议召开情况 上海家化联合股份有限公司八届十二次董事会于 2023 年 8 月 28 日以现场及 视频方式召开，会议通知于 2023 年 8 月 18 日以邮件方式发出。会议应参加董事 7 人，实际参加董事 7 人，会议由董事长潘秋生先生主持，监事和高级管理人员 列席了会议，符合《公司法》及《公司章程》的有关规定。 二、董事会会议审议情况 证券代码：600315 证券简称：上海家化 公告编号：临 2023-031 上海家化联合股份有限公司 八届十二次董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 会议审议并通过了如下议案： 1、审议通过公司 2023 年半年度报告； 表决情况：7 票同意，0 票反对，0 票弃权，通过本议案。 《上海家化联合股份有限公司2023年半年度报告》及摘要请见上海证券交易 所网站。 2、审议通过关于调整公司 2020年和 2022年限制性股票激励计划回购价格及 2021 年股票期权激励计划行权价格的议案； 表决情况：6 票同意，0 票反对，0 票弃权，1 票回避，通过本议 ...

证券代码：600315 证券简称：上海家化 公告编号：临 2023-033 上海家化联合股份有限公司 关于 2023 年第二季度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据上海证券交易所《上市公司行业信息披露指引第十三号—化工》的要求、 现将公司 2023 年第二季度主要经营数据披露如下： 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 产量(支) | 销量(支) | 营业收入（元） | | --- | --- | --- | --- | | 护肤 | 55,087,831 | 12,751,533 | 462,136,733.96 | | 个护家清 | 183,577,735 | 69,571,408 | 656,923,487.98 | | 母婴 | 63,323,448 | 31,061,408 | 469,293,413.02 | | 合作品牌 | 6,148,492 | 2,979,598 | 56,839,410.24 | 注：护肤品类，包括佰草集、玉泽、典萃、高夫、双妹 ...

上海家化独立董事关于八届十二次董事会相关议案的独立意见 一、关于调整公司 2020年和2022年限制性股票激励计划回购价格及 2021年股 票期权激励计划行权价格的独立意见 公司董事会对 2020年限制性股票激励计划和 2022年限制性股票激励计划 回购价格及 2021 年股票期权激励计划行权价格的调整符合《公司章程》、《管理 办法》等相关法律法规、规章和规范性文件以及公司《2020年激励计划(2022 年 8 月修订)》、《2021 年激励计划(草案修订稿)》和《2022 年激励计划(草 案)》的相关规定,且本次调整已取得股东大会授权,调整程序合法、合规,不 存在损害公司及全体股东利益的情况。 综上所述,我们一致同意公司关于 2020年限制性股票激励计划、2021 年 股票期权激励计划和 2022 年限制性股票激励计划的调整事项。 独立董事签字: 王鲁军 运国非 肖立荣 2023 年 8 月 28 日 ...